How the Mongolian gerbil may help speed recovery of a rare inner ear problem

To patients of P. Ashley Wackym, a surgical otologist-neurotologist at Rutgers Robert Wood Johnson Medical School, a diagnosis of superior semicircular canal dehiscence (SSCD) can feel like a death sentence.

https://www.lifetechnology.com/blogs/life-technology-medical-news/how-the-mongolian-gerbil-may-help-speed-recovery-of-a-rare-inner-ear-problem

Buy SuperforceX™

33 million kids vaccinated against polio in southern Africa

More than 33 million children in several southern African countries have been vaccinated against polio, part of ongoing efforts to eradicate the infectious paralytic disease that has been largely contained in much of the world, the World Health Organization announced on Friday.

https://www.lifetechnology.com/blogs/life-technology-medical-news/33-million-kids-vaccinated-against-polio-in-southern-africa

Buy SuperforceX™

Commentary: Two decades of stagnant funding have rendered Canada uncompetitive in biomedical research

You may imagine that the hard part of being a Canadian scientist is having a bright idea. However, while curiosity, persistence and inventiveness are prerequisites for scientific success, the major obstacle to being a biomedical scientist in Canada is obtaining research funding.

https://www.lifetechnology.com/blogs/life-technology-medical-news/commentary-two-decades-of-stagnant-funding-have-rendered-canada-uncompetitive-in-biomedical-research

Buy SuperforceX™

Do beach cabanas actually protect you from the sun?

You may have seen them popping up on beaches everywhere—colorful, breezy, shady, beach cabanas.

https://www.lifetechnology.com/blogs/life-technology-medical-news/do-beach-cabanas-actually-protect-you-from-the-sun

Buy SuperforceX™

Rucaparib efficacious in metastatic castration-resistant prostate cancer

For patients with metastatic castration-resistant prostate cancer, treatment with rucaparib is associated with significantly longer duration of imaging-based progression-free survival compared with a control medication, according to a study published online Feb. 16 in the New England Journal of Medicine to coincide with the American Society of Clinical Oncology annual Genitourinary Cancers Symposium, held from Feb. 16 to 18 in San Francisco.

https://www.lifetechnology.com/blogs/life-technology-medical-news/rucaparib-efficacious-in-metastatic-castration-resistant-prostate-cancer

Buy SuperforceX™